Esketamine nasal spray (Spravato®): Clinical trials in “treatment-resistant depression”

This page is for reference only. Clinicians do not need to read this page. First, here are the FOUR published short-term, randomized, double-blind placebo-controlled clinical trials of intranasal esketamine for the treatment of major depressive disorder that have been published as of January 2020 (chronologically by date of publication). Then, I have listed a comparison with…